Salmeterol inhibits anaphylactic histamine release from guinea-pig isolated mast cells. 1994

G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.

Salmeterol (1 nM-100 microM) showed an inhibitory action on anaphylactic histamine release from mast cells, isolated from pleural and peritoneal cavities of actively sensitized guinea-pigs and stimulated by incubation with allergen. The effect is concentration-dependent and is reduced by the beta-adrenoceptor antagonist propranolol (1 microM). This study supports the hypothesis of an anti-inflammatory property of salmeterol, which concerns cells involved in the early phases of asthma.

UI MeSH Term Description Entries
D008297 Male Males
D008407 Mast Cells Granulated cells that are found in almost all tissues, most abundantly in the skin and the gastrointestinal tract. Like the BASOPHILS, mast cells contain large amounts of HISTAMINE and HEPARIN. Unlike basophils, mast cells normally remain in the tissues and do not circulate in the blood. Mast cells, derived from the bone marrow stem cells, are regulated by the STEM CELL FACTOR. Basophils, Tissue,Basophil, Tissue,Cell, Mast,Cells, Mast,Mast Cell,Tissue Basophil,Tissue Basophils
D010529 Peritoneal Cavity The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the STOMACH. The two sacs are connected by the foramen of Winslow, or epiploic foramen. Greater Sac,Lesser Sac,Omental Bursa,Bursa, Omental,Cavity, Peritoneal,Sac, Greater,Sac, Lesser
D010994 Pleura The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid. Parietal Pleura,Visceral Pleura,Pleura, Parietal,Pleura, Visceral
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D000068299 Salmeterol Xinafoate A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Salmeterol,Serevent,Xinafoate, Salmeterol

Related Publications

G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
January 1977, Monographs in allergy,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
April 1979, Agents and actions,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
June 1967, The Journal of pharmacy and pharmacology,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
April 1978, Naunyn-Schmiedeberg's archives of pharmacology,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
April 1979, Agents and actions,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
January 1981, Arzneimittel-Forschung,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
January 1972, International archives of allergy and applied immunology,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
July 1966, Kumamoto Igakkai zasshi. The Journal of the Kumamoto Medical Society,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
August 1981, Biochemical pharmacology,
G Gentilini, and M Grazia di Bello, and S Raspanti, and D Bindi, and S Mugnai, and L Zilletti
January 1968, International archives of allergy and applied immunology,
Copied contents to your clipboard!